Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
---|---|---|---|---|---|---|---|---|
CancerPDF_ID3539 | RAHGQESAIF | Secreted and transmembrane protein 1 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
CancerPDF_ID4197 | AHGQESAIFNEVAPGY | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID4204 | AIFNEVAPGYFSRDGWQLQV | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID4985 | FNEVAPGYFSRDGWQL | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID4986 | FNEVAPGYFSRDGWQLQV | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID4987 | FNEVAPGYFSRDGWQLQVQGGVAQ | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID4988 | FNEVAPGYFSRDGWQLQVQGGVAQL | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID5036 | FSRDGWQLQVQGGVA | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID5037 | FSRDGWQLQVQGGVAQ | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID5372 | HGQESAIFNEVAPGY | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6262 | NEVAPGYFSRDGWQ | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6263 | NEVAPGYFSRDGWQLQV | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6264 | NEVAPGYFSRDGWQLQVQGGVAQ | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6265 | NEVAPGYFSRDGWQLQVQGGVAQL | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6639 | RAHGQESAIFNEVAPGY | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6645 | RDGWQLQVQGGVAQ | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6646 | RDGWQLQVQGGVAQL | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6755 | SAIFNEVAPGY | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6756 | SAIFNEVAPGYFSRDGWQL | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID7063 | SRDGWQLQVQGGVAQ | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID7064 | SRDGWQLQVQGGVAQL | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID7709 | VAPGYFSRDGWQLQVQGGVAQ | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID7710 | VAPGYFSRDGWQLQVQGGVAQL | Secreted and transmembrane protein 1 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID9990 | RAHGQESAIF | Secreted and transmembrane protein 1 | Urine | 1115.5425 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10029 | VIKGARDSHAGL | Secreted and transmembrane protein 1 | Urine | 1223.6697 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10085 | LVIKGARDSHAGL | Secreted and transmembrane protein 1 | Urine | 1336.7666 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10287 | SRDGWQLQVQGGVAQL | Secreted and transmembrane protein 1 | Urine | 1741.8727 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10343 | YMWHLVGHQRNNRQ | Secreted and transmembrane protein 1 | Urine | 1838.8866 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10485 | YMWHLVGHQRNNRQVTL | Secreted and transmembrane protein 1 | Urine | 2152.0971 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10759 | FSHVNIKL | Secreted and transmembrane protein 1 | Urine | 957.5455 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |